Fetal fibronectin and bacterial vaginosis are associated with preterm birth in women who are symptomatic for preterm labor

American Journal of Obstetrics and Gynecology

Volumn 190, Issue 6, 2004, Pages 1582-1587

  Stevens, Amy O ^a   Chauhan, Suneet P ^a   Magann, Everett F ^a   Martin, Rick W ^a   Bofill, James A ^a   Cushman, Julie L ^a   Morrison, John C ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Bacterial vaginosis; Fetal fibronectin; Preterm birth

Indexed keywords

FIBRONECTIN; INDOMETACIN; MAGNESIUM SULFATE; NIFEDIPINE;

ADULT; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIVERY; FEMALE; FETUS; GESTATION PERIOD; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; PREMATURE LABOR; PRIORITY JOURNAL; SYMPTOMATOLOGY; VAGINITIS;

EID: 3442897385     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2004.03.059     Document Type: Conference Paper

References (17)

1. March of Dimes Birth Defects Foundation. March of Dimes updates: taking action against prematurity. Contemp Obstet Gynecol. 2003;92-104
2. Ascarelli M.H., Morrison J.C. Use of fetal fibronectin in clinical practice. Obstet Gynecol Surv. 52:1997;S1-S12
3. Wood N.S., Marlow N., Costeloe K., Gibson A.T., Wilkinson A.R. Neurologic and developmental disability after extremely preterm birth: EPICure Study Group. N Engl J Med. 343:2000;378-384
4. Gibbs R.S., Eschenbach D.A. Use of antibiotics to prevent preterm birth. Am J Obstet Gynecol. 177:1997;375-380
5. Goldenberg R.L., Hauth J.C., Andrews W.W. Intrauterine infection and preterm delivery. N Engl J Med. 342:2000;1500-1507
6. Locksmith G., Duff P. Infection, antibiotics, and preterm delivery. Semin Perinatol. 25:2001;295-309
7. Andrews W.W., Hauth J.C., Goldenberg R.L. Infection and preterm birth. Am J Perinatol. 17:2000;357-365
8. Meis P.H., Goldenberg R.L., Mercer B., Moawad A., Das A., McNellis D., et al. The preterm prediction study: significance of vaginal infections. Am J Obstet Gynecol. 173:1995;1231-1235
9. McGregor J.A., French J.I., Parker R., Draper D., Patterson E. Prevention of premature birth by screening and treatment for common genital tract infections: results of a prospective controlled evaluation. Am J Obstet Gynecol. 173:1995;157-167
10. Andrews W.W., Sibai B.M., Thom E.A., Dudley D., Ernest J.M., McNellis D., et al. Randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin positive women. Obstet Gynecol. 101:2003;847-855
11. Goldenberg R.L., Mercer B.M., Meis P.H., Copper R.L., Das A., McNellis D. The preterm prediction study: fetal fibronectin testing and spontaneous preterm birth. Obstet Gynecol. 87:1996;643-648
12. McGregor J.A., French J.I. Bacterial vaginosis in pregnancy. Obstet Gynecol Surv. 55:2000;S1-S19
13. Plaut M.M., Smith W., Kennedy K. Fetal fironectin: the impact of a rapid test on the treatment of women with preterm labor symptoms. Am J Obstet Gynecol. 188:2003;1958-1995
14. Lamont R.F., Duncan S.L.B., Mandal D., Bassett P. Intravaginal clindamycin to reduce preterm birth in women with abnormal genital tract flora. Obstet Gynecol. 101:2003;516-522
15. Leitich H., Brunbauer M., Bodner-Adler B., Kaider A., Egarter C., Husslein P. Antibiotic treatment of bacterial vaginosis in pregnancy: a meta-analysis. Am J Obstet Gynecol. 188:2003;752-758
16. Crane J.M.G., Armson B.A., Dodds L., Feinbert R.F., Kennedy W., Kirkland S.A. Risk scoring, fetal fibronectin, and bacterial vaginosis to predict preterm delivery. Obstet Gynecol. 93:1999;517-522
17. Morrison J.C., Naeff R.W., Botti J.J., Katz M., Belluomini J.M., McLaughlin B.N. Prediction of spontaneous preterm birth by fetal fibronectin and uterine activity. Obstet Gynecol. 87:1996;649-655